Twist Bioscience Corp (TWST) Stock Analysis

Twist Bioscience Corp (TWST) is a publicly traded company in the HEALTHCARE sector. It trades at $70.15, carries a market capitalization of $4.23B. This page summarizes the public market data, fundamentals, and frequently asked questions for TWST, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $70.15
• Market Cap: $4.23B
• EPS: $-1.32
• 52-Week High: $71.04
• 52-Week Low: $23.30

Market Sentiment

Twist Bioscience Corp currently has a Neutral sentiment score of 0.01.

About Twist Bioscience Corp

Twist Bioscience Corporation (TWST) is a prominent player in the synthetic biology sector, focused on the design and manufacture of high-quality synthetic DNA products for applications spanning pharmaceuticals, agriculture, and industrial biotechnology. Based in South San Francisco, California, the company utilizes its proprietary DNA synthesis technology to provide scalable, cost-effective solutions that meet the growing demands of its diverse clientele. With a commitment to innovation and e...

GNG Research Analysis

GNG Research scores Twist Bioscience Corp (TWST) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TWST.

Frequently Asked Questions

Does TWST pay dividends?

Twist Bioscience Corp (TWST) does not currently pay a regular dividend.

What is TWST's market cap?

Twist Bioscience Corp (TWST) has a market capitalization of $4.23B with a current stock price of $70.15.